May play a role in the morphogenesis of the inner and craniofacial ear during embryonic development. Can act inside the otic vesicle epithelium to control the formation of the lateral semicircular canal in the uterus.
May play a role in the morphogenesis of the inner and craniofacial ear during embryonic development. May act within the otic vesicle epithelium to control the formation of the lateral semicircular canal in the inner ear, possibly by limiting the expression of NTN1.
Sensitivity
Sensitivity of dosage: 2.4 ng/ml.
Measurement range
Dose range: 2.4 to 500 ng/ml.
Duration of dosing
Total duration of dosing: 4 h 45 min.
Reproducibility
Coefficient of intradose variation < 10%, interdose < 12%.
Technical specifications
| General |
| Brand | Invitrogen |
| Supplier ref. (Fisher Scientific) | 17767683 |
| Specifications |
| Accession number | Q6UXM1 |
| Dose range | 2.4 to 500 ng/ml |
| Sensitivity of the dosage | 2.4 ng/ml |
| Conjugate | Biotin |
| Product type | ELISA |
| Type of sample | Plasma, Serum, Surnatant |
| For use with (equipment) | Colorimetric microplate reader |
| Genetic identification (Enter) | 121227 |
| Gene symbol(s) | LRIG3 |
| Coefficient of inter-dose variation | < 12% |
| Coefficient of intra-dose variation | < 10% |
| Contents of kits | 96-well pre-coated sheetings, etc., at the same time as the pre-casting plate, at the same time as the pre-casting plate. |
| Marker or dye | HRP |
| Quantity | 10 x 96 tests |
| Regulatory status | RUO |
| Target | LRIG3 |
| Test time | 1 h 20 min |
| Physical characteristics |
| Volume of sample | Supernatant, 50 μl-Serum, 50 μl-Plasma, 50 μl |
| Storage and shipping |
| Storage conditions | 2°C to 8°C |
| Total duration of dosing | 4 h 45 min |
Origin and customs
| Manufacturer ref. | EH306RBX10 |
|---|
| Country of origin | United States |
|---|
| HS customs code | 3002 12 00 00 |
|---|
A question or a specific configuration?
Contact us for a quote.